Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats - PubMed (original) (raw)

. 1997 May;127(5 Suppl):907S-911S.

doi: 10.1093/jn/127.5.907S.

Affiliations

• PMID: 9164261
• DOI: 10.1093/jn/127.5.907S

Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats

S W French et al. J Nutr. 1997 May.

Abstract

The role of cytochrome P450 metabolism of fatty acids and lipid peroxidation in the alterations of the fatty acid composition of the liver and liver pathology was investigated. The CYP2E1 inhibitors partially prevented CYP2E1 induction by ethanol and completely blocked lipid peroxidation. However, the liver pathology induced by ethanol was only partially prevented as was the decrease in arachidonic acid in total liver lipid, triglycerides and cholesterol esters. This means that liver peroxidation induced by ethanol can not completely account for the liver pathology or the decrease in arachidonic acid caused by ethanol. Lauric acid omega-1 hydroxidation by the liver microsomes in vitro was increased by ethanol and partially blocked by CYP2E1 inhibitors. However, although ethanol feeding increased the total hydroxidation and epoxidation of arachidonic acid, these were not inhibited by CYP2E1 inhibitors. Thus the ethanol-induced arachidonic acid depletion is not likely due to CYP2E1 metabolism of arachidonic acid, since the severity of liver pathology correlated negatively with the decrease in arachidonic acid in the ethanol-fed rats. The increase in its metabolism by microsomes and decrease in synthesis may be an important mechanism of ethanol-induced liver injury.

PubMed Disclaimer

Similar articles

• CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet.
  Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW. Morimoto M, et al. J Nutr. 1995 Dec;125(12):2953-64. doi: 10.1093/jn/125.12.2953. J Nutr. 1995. PMID: 7500173
• Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors.
  Morimoto M, Hagbjörk AL, Wan YJ, Fu PC, Clot P, Albano E, Ingelman-Sundberg M, French SW. Morimoto M, et al. Hepatology. 1995 Jun;21(6):1610-7. Hepatology. 1995. PMID: 7768506
• Iron and CYP2E1-dependent oxidative stress and toxicity.
  Cederbaum AI. Cederbaum AI. Alcohol. 2003 Jun;30(2):115-20. doi: 10.1016/s0741-8329(03)00104-6. Alcohol. 2003. PMID: 12957295 Review.
• Role of microsomal enzymes in development of alcoholic liver diseases.
  Konishi M, Ishii H. Konishi M, et al. J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S7-10. doi: 10.1111/j.1440-1746.2006.04638.x. J Gastroenterol Hepatol. 2007. PMID: 17567472 Review.

Cited by

• Higher sensitivity of female cells to ethanol: methylation of DNA lowers Cyp2e1, generating more ROS.
  Penaloza CG, Cruz M, Germain G, Jabeen S, Javdan M, Lockshin RA, Zakeri Z. Penaloza CG, et al. Cell Commun Signal. 2020 Jul 11;18(1):111. doi: 10.1186/s12964-020-00616-8. Cell Commun Signal. 2020. PMID: 32653010 Free PMC article.
• The effect of propranolol on gene expression during the blood alcohol cycle of rats fed ethanol intragastrically.
  Li J, Bardag-Gorce F, Oliva J, French BA, Dedes J, French SW. Li J, et al. Exp Mol Pathol. 2010 Feb;88(1):32-7. doi: 10.1016/j.yexmp.2009.11.003. Epub 2009 Nov 17. Exp Mol Pathol. 2010. PMID: 19925788 Free PMC article.
• Effects of Tobacco Nicotine-Derived Nitrosamine Ketone (NNK) Exposures on Brain Alcohol Metabolizing Enzyme Activities.
  Yalcin EB, Tong M, Gallucci G, de la Monte SM. Yalcin EB, et al. Drug Metab Lett. 2018;12(2):117-124. doi: 10.2174/1872312812666180611115418. Drug Metab Lett. 2018. PMID: 29886839 Free PMC article.
• CYP2E1 and oxidative liver injury by alcohol.
  Lu Y, Cederbaum AI. Lu Y, et al. Free Radic Biol Med. 2008 Mar 1;44(5):723-38. doi: 10.1016/j.freeradbiomed.2007.11.004. Epub 2007 Nov 17. Free Radic Biol Med. 2008. PMID: 18078827 Free PMC article. Review.
• CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
  Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. Leclercq IA, et al. J Clin Invest. 2000 Apr;105(8):1067-75. doi: 10.1172/JCI8814. J Clin Invest. 2000. PMID: 10772651 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems